Charlottesville, VA, United States of America

Jerome Ferrance


Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 2008-2019

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Jerome Ferrance

Introduction

Jerome Ferrance is a notable inventor based in Charlottesville, VA, with a significant contribution to the field of cancer diagnostics. He holds a total of 9 patents, showcasing his innovative approach to medical technology and research.

Latest Patents

One of his latest patents is focused on "Micro-RNA based diagnoses of ovarian and other cancers via sub-terahertz vibrational spectroscopy." This method involves analyzing body fluid samples to determine the presence of cancer by utilizing sub-THz resonance spectroscopy. The analysis is conducted at various frequencies between 0.05 and 1.0 THz to identify specific Micro-RNAs associated with cancer. Another significant patent is titled "Terahertz spectroscopy characterization with high spectral and spatial resolution for biological and chemical sensing and method of use." This invention enhances the analysis of biological cells or spores by employing enhanced THz coupling to molecules, allowing for precise identification through a database of spectroscopic signatures.

Career Highlights

Jerome Ferrance has worked at the University of Virginia, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of cancer diagnostics through innovative technologies.

Collaborations

He has collaborated with notable individuals in his field, including James P. Landers and Matthew R. Begley, further enhancing the impact of his research and inventions.

Conclusion

Jerome Ferrance's contributions to cancer diagnostics through his innovative patents highlight his role as a leading inventor in the medical technology sector. His work continues to pave the way for advancements in the detection and understanding of cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…